杨萍, 常保超, 邓蓉, 郑晶, 曹雪, 陈卫东. 血浆同型半胱氨酸检测及其在糖尿病肾病中的应用[J]. 蚌埠医科大学学报, 2014, 38(1): 115-117.
    引用本文: 杨萍, 常保超, 邓蓉, 郑晶, 曹雪, 陈卫东. 血浆同型半胱氨酸检测及其在糖尿病肾病中的应用[J]. 蚌埠医科大学学报, 2014, 38(1): 115-117.
    YANG Ping, CHANG Bao-chao, DENG Rong, ZHENG Jing, CAO Xue, CHEN Wei-dong. Relationship between plasma homocysteine and diabetic nephropathy[J]. Journal of Bengbu Medical University, 2014, 38(1): 115-117.
    Citation: YANG Ping, CHANG Bao-chao, DENG Rong, ZHENG Jing, CAO Xue, CHEN Wei-dong. Relationship between plasma homocysteine and diabetic nephropathy[J]. Journal of Bengbu Medical University, 2014, 38(1): 115-117.

    血浆同型半胱氨酸检测及其在糖尿病肾病中的应用

    Relationship between plasma homocysteine and diabetic nephropathy

    • 摘要: 目的:观察糖尿病肾病(DN)患者血浆同型半胱氨酸(Hcy)水平,分析Hcy水平与DN的关系。方法:选择DN 104例(其中合并心脑血管疾病者50例)和健康对照组38名,用循环酶法测定其血浆Hcy水平,同时检测血糖(Glu)、血肌酐(ScR)、总胆固醇(TC)、三酰甘油(TG)及高敏C反应蛋白(hs-CRP)水平。结果:DN患者血浆Hcy水平明显高于健康对照组(P0.01),其中并发心脑血管疾病者Hcy及hs-CRP水平均明显高于无心脑血管疾病者(P0.01)。Hcy与ScR、TC、TG以及hsCRP均呈显著正相关关系(P0.05~P0.01)。结论:DN患者血浆Hcy水平增高,Hcy可能参与了DN患者心脑血管疾病的发生;降低血浆Hcy水平,可能会减少DN患者心脑血管并发症的发生。

       

      Abstract: Objective:To observe the level of plasma homocysteine(Hcy) in patients with diabetic nephropathy(DN) and analyze the relationship between the level of Hcy and DN.Methods:The plasma Hcy level of 104 cases of DN including 50 case who were combined with heart and cerebrovascular diseases and 38 healthy controls was measured by enzymatic cycling; their blood glucose (Glu),serum creatinine(Scr),total cholesterol(TC),triglyceride(TG) and high-sensitivity C-reactive protein(hs-CRP) were also measured.Results:The plasma Hcy level of patients with DN was significantly higher than that of the healthy control(P 0.01); the plasma level of Hcy and hs-CRP in DN patients combined with cardio-cerebral vascular disease were significantly higher than that of DN patients free of heart and cerebrovascular diseases(P 0.01).Hcy was positive correlated to Scr,TC,TG and hs-CRP (P 0.05 to P 0.01).Conclusions:The level of Hcy is elevated in patients with DN; Hcy may participate in the genesis of heart and cerebrovascular disease in patients with DN; the incidence of cardio-cerebral vascular diseases in DN patients may be reduced by lowering the plasma Hcy level.

       

    /

    返回文章
    返回